欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号FI/H/0925/001
药品名称Betahistine Abbott 24 mg
活性成分
    • betahistine dihydrochloride 24.0 mg
剂型Orodispersible tablet
上市许可持有人Abbott Laboratories Limited Abbott House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire SL6 4XE United Kingdom
参考成员国 - 产品名称Finland (FI)
Betahistine Abbott
互认成员国 - 产品名称
    • France (FR)
许可日期2019/02/12
最近更新日期2022/06/30
药物ATC编码
    • N07CA01 betahistine
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Informed Consent Art 10c Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase